WestEnd Advisors’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6
| Closed | -$454 | – | 425 |
|
|
2026
Q1 | $454 | Hold |
6
| – | – | ﹤0.01% | 316 |
|
|
2025
Q4 | $447 | Sell |
6
-1
| -14% | -$73 | ﹤0.01% | 320 |
|
|
2025
Q3 | $472 | Sell |
7
-3
| -30% | -$199 | ﹤0.01% | 321 |
|
|
2025
Q2 | $652 | Buy |
10
+1
| +11% | +$60 | ﹤0.01% | 251 |
|
|
2025
Q1 | $556 | Buy |
9
+6
| +200% | +$398 | ﹤0.01% | 265 |
|
|
2024
Q4 | $216 | Hold |
3
| – | – | ﹤0.01% | 248 |
|
|
2024
Q3 | $244 | Hold |
3
| – | – | ﹤0.01% | 267 |
|
|
2024
Q2 | $223 | Sell |
3
-1
| -25% | -$75 | ﹤0.01% | 252 |
|
|
2024
Q1 | $312 | Hold |
4
| – | – | ﹤0.01% | 200 |
|
|
2023
Q4 | $286 | Buy |
4
+1
| +33% | +$70 | ﹤0.01% | 201 |
|
|
2023
Q3 | $208 | Buy |
+3
| New | +$227 | ﹤0.01% | 225 |
|
|
2023
Q1 | – | Sell |
-3
| Closed | -$242 | – | 215 |
|
|
2022
Q4 | $224 | Hold |
3
| – | – | ﹤0.01% | 219 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 227 |
|
|
2022
Q2 | $207 | Buy |
+3
| New | +$223 | ﹤0.01% | 216 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | -$144 | – | 258 |
|
|
2021
Q4 | $153 | Buy |
+2
| New | +$147 | ﹤0.01% | 293 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 286 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 296 |
|
Other funds holding HOLX
WestEnd Advisors's HOLX Position: Q2 2026 in Review
WestEnd Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 6 shares — an estimated $454 sold.
WestEnd Advisors first reported a position in HOLX in Q4 2021 and held it in 15 quarters. The position peaked at $652 in Q2 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- WestEnd Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- WestEnd Advisors sold 6 Hologic shares in Q2 2026, an estimated $454.
- WestEnd Advisors first reported a position in Hologic in Q4 2021 and held it in 15 quarters.
- WestEnd Advisors's Hologic position peaked at $652 in Q2 2025.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.